Detalhe da pesquisa
1.
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types.
Cell Mol Life Sci
; 79(4): 204, 2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332383
2.
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial.
Cancer
; 126(22): 4859-4866, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910476
3.
High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts.
Int J Cancer
; 143(11): 3027-3034, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29923614
4.
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.
Cancer
; 123(13): 2444-2451, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464211
5.
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).
Breast Cancer Res Treat
; 164(3): 571-580, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28484925
6.
Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy.
Cancer
; 117(21): 5013-20, 2011 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21456017
7.
Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics.
Cells
; 10(2)2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670680
8.
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer.
Sci Rep
; 9(1): 19761, 2019 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31875000
9.
Serum osteoprotegerin levels in healthy controls and cancer patients.
Clin Cancer Res
; 8(7): 2306-10, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12114435
10.
Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
Int J Oncol
; 22(2): 425-30, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12527944
11.
Would screening for lung cancer benefit 75- to 84-year-old residents of the United States?
Front Oncol
; 4: 37, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24639950
12.
Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans.
Bone
; 61: 176-85, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24486955
13.
Identification of PTHrP(12-48) as a plasma biomarker associated with breast cancer bone metastasis.
Cancer Epidemiol Biomarkers Prev
; 22(5): 972-83, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23462923
14.
Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy.
PLoS One
; 7(12): e51379, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23300545
15.
Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14.
J Clin Oncol
; 29(27): 3605-10, 2011 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21859992
16.
Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients.
Cancer
; 117(3): 517-25, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20862742
17.
Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab.
Cancer
; 116(22): 5168-78, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20661914
18.
Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patients.
Clin Cancer Res
; 16(16): 4226-35, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20664024
19.
Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer.
Cancer
; 113(6): 1294-301, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18661530
20.
Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer.
J Clin Oncol
; 26(16): 2653-8, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18443351